OSE Pharma SA (OSE) — Cash Flow Quality Index
OSE Pharma SA (OSE) has a Cash Flow Quality Index of 1.17x as of June 2024. Operating cash flow of €66.63 Million exceeds net income of €57.17 Million, indicating high earnings quality where cash backs reported profits. Explore OSE Pharma SA (OSE) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
OSE Pharma SA Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for OSE Pharma SA across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of OSE Pharma SA to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for OSE Pharma SA (2016–2024)
Year-by-year earnings quality comparison for OSE Pharma SA. For live market cap and the full company financial profile, see OSE stock market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.29x | €48.44 Million | €37.45 Million | ▲ +559.4% |
| 2018 | 0.20x | €1.08 Million | €5.49 Million | ▲ +492.7% |
| 2016 | 0.03x | €684.00K | €20.67 Million | — |